Gene expression profile of residual breast cancer after doxorubicin and cyclophosphamide neoadjuvant chemotherapy

Oncology Reports

Volumn 22, Issue 4, 2009, Pages 805-813

  Folgueira, Maria Aparecida Azevedo Koike ^a   Brentani, Helena ^b   Carraro, Dirce Maria ^b   Filho, Mateus De Camargo Barros ^a   Katayama, Maria Lucia Hirata ^a   De Abreu, Ana Paula Santana ^c   Barbosa, Edson Mantovani ^c   De Oliveira, Célia Tosello ^c   Patrao, Diogo F C ^b   Mota, Louise D ^b   Mourão, Mario Netto ^b   Caldiera, Jose Roberto Figaro ^d   Bretani, Maria Mitzi ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b A C CAMARGO CANCER CENTER   (Brazil)

^c Instituto Brasileiro de Controle do Cancer   (Brazil)

^d Hospital Amaral Carvalho   (Brazil)

Author keywords

Breast neoplasms; Doxorubicin; Drug resistance; Gene expression profiling; Microarray analysis; Neoadjuvant therapy; Reverse transcriptase polymerase chain reaction

Indexed keywords

COMPLEMENTARY DNA; CONNECTIVE TISSUE GROWTH FACTOR; CYCLOPHOSPHAMIDE; DOXORUBICIN; MANNOSE BINDING LECTIN 2; MICROTUBULE ASSOCIATED PROTEIN 4; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 1; ONCOPROTEIN; POLO LIKE KINASE 3; PROTEIN ABI3; PROTEIN ARHE; PROTEIN AXUD1; PROTEIN BTG2; PROTEIN METTL3; PROTEIN NXN; PROTEIN SASHI; PROTEIN SGK; PROTEIN SMOC2; PROTEIN STARD13; PROTEIN TOM1L2; PROTEIN WWP2; SEPTIN; SEPTIN 1; SLIT PROTEIN; SLIT3 PROTEIN; TRANSCRIPTION FACTOR FOSB; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN RECEPTOR; ZINC FINGER PROTEIN; ZINC FINGER PROTEIN 189;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RESISTANCE; CANCER SURVIVAL; CELL DEATH; CLINICAL ARTICLE; DNA MICROARRAY; DOWN REGULATION; GENE EXPRESSION PROFILING; GENE FUNCTION; HUMAN; HUMAN TISSUE; MULTIPLE CYCLE TREATMENT; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; UPREGULATION;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CONNECTIVE TISSUE GROWTH FACTOR; CYCLOPHOSPHAMIDE; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; DUAL SPECIFICITY PHOSPHATASE 1; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; MAP KINASE KINASE 4; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM, RESIDUAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR MARKERS, BIOLOGICAL;

EID: 70350371085     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000503     Document Type: Article

References (29)

1. Fisher B, Brown A, Mamounas E, et al: Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18. J Clin Oncol 15: 2483-2493, 1997.
2. Van der Hage JA, van de Velde CJ, Julien JP, Tubiana-Hulin M, Vandervelden C and Duchateau L: Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902. J Clin Oncol 19: 4224-4237, 2001.
3. Bear HD, Anderson S, Brown A, et al: National Surgical Adjuvant Breast and Bowel Project Protocol B-27: the effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: preliminary results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27. J Clin Oncol 22: 4165-4174, 2003.
4. Smith IC, Heys SD, Hutcheon AW, et al: Neoadjuvant chemotherapy in breast cancer: significantly enhanced response with docetaxel. J Clin Oncol 20: 1456-1466, 2002.
5. Therasse P, Arbuck SG, Eisenhauer EA, et al: New guidelines to evaluate the response to treatment in solid tumors European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92: 205-216, 2000.
6. Brentani RR, Carraro DM, Verjovski-Almeida S, et al: Gene expression arrays in cancer research: methods and applications. Crit Rev Oncol Hematol 54: 95-105, 2005.
7. Folgueira MA, Carraro DM, Brentani H, et al: Gene expression profile associated with response to doxorubicin-based therapy in breast cancer. Clin Cancer Res 11: 7434-7443, 2005.
8. Roela RA, Carraro DM, Brentani HP, et al: Gene stage-specific expression in the microenvironment of pediatric myelodysplastic syndromes. Leuk Res 31: 579-589, 2007.
9. Maschietto M, de Camargo B, Brentani H, et al: Molecular profiling of isolated histological components of Wilms tumor implicates a common role for the Wnt signaling pathway in kidney and tumor development. Oncology 75: 81-91, 2008.
10. Castro NP, Osorio CA, Torres C, et al: Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma. Breast Cancer Res 10: R87, 2008.
11. Storey JD: A direct approach to false discovery rates. J Roy Stat Soc B 64: 479-498, 2002.
12. Saeed AI, Sharov V, White J, et al: TM4: a free, open-source system for microarray data management and analysis. Biotechniques 34: 374-378, 2003.
13. Vandesompele J, De Preter K, Pattyn F, et al: Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3: R0034, 2002.
14. Pfaffl MW: A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29: e45, 2001.
15. Draghici S, Khatri P, Martins RP, Ostermeier GC and Krawetz SA: Global functional profiling of gene expression. Genomics 81: 98-104, 2003.
16. Sotiriou C, Powles TJ, Dowsett M, et al: Gene expression profiles derived from fine needle aspiration correlate with response to systemic chemotherapy in breast cancer. Breast Cancer Res 4: R3, 2002.
17. Modlich O, Prisack HB, Munnes M, Audretsch W and Bojar H: Immediate gene expression changes after the first course of neoadjuvant chemotherapy in patients with primary breast cancer disease. Clin Cancer Res 10: 6418-6431, 2004.
18. Cleator S, Tsimelzon A, Ashworth A, et al: Gene expression patterns for doxorubicin (Adriamycin) and cyclophosphamide (cytoxan) (AC) response and resistance. Breast Cancer Res Treat 95: 229-233, 2006.
19. Hannemann J, Oosterkamp HM, Bosch CA, et al: Changes in gene expression associated with response to neoadjuvant chemotherapy in breast cancer. J Clin Oncol 23: 3331-3342, 2005.
20. Perou CM, Sørlie T, Eisen MB, et al: Molecular portraits of human breast tumours. Nature 406: 747-752, 2000.
21. Troester MA, Hoadley KA, Sorlie T, et al: Cell-type-specific responses to chemotherapeutics in breast cancer. Cancer Res 64: 4218-4226, 2004.
22. Mallory JC, Crudden G, Oliva A, Saunders C, Stromberg A and Craven RJ: A novel group of genes regulates susceptibility to antineoplastic drugs in highly tumorigenic breast cancer cells. Mol Pharmacol 68: 1747-1756, 2005.
23. Luo Y and Leverson JD: New opportunities in chemosensitization and radiosensitization: modulating the DNA-damage response. Expert Rev Anticancer Ther 5: 333-342, 2005.
24. Elmore LW, Di X, Dumur C, Holt SE and Gewirtz DA: Evasion of a single-step, chemotherapy-induced senescence in breast cancer cells: implications for treatment response. Clin Cancer Res 11: 2637-2643, 2005.
25. Yi X, Bekeredjian R, DeFilippis NJ, Siddiquee Z, Fernandez E and Shohet RV: Transcriptional analysis of doxorubicin-induced cardiotoxicity. Am J Physiol Heart Circ Physiol 290: 1098-1102, 2006.
26. Kang Y, Siegel PM, Shu W, et al: A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 3: 537-549, 2003.
27. Wang HY, Cheng Z and Malbon CC: Overexpression of mitogen-activated protein kinase phosphatases MKP1, MKP2 in human breast cancer. Cancer Lett 191: 229-237, 2003.
28. Small GW, Shi YY, Higgins LS and Orlowski RZ: Mitogen-activated protein kinase phosphatase-1 is a mediator of breast cancer chemoresistance. Cancer Res 67: 4459-4466, 2007.
29. Liebermann DA, Gregory B and Hoffman B: AP-1 (Fos/Jun) transcription factors in hematopoietic differentiation and apoptosis. Int J Oncol 12: 685-700, 1998.